No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
688393 Guangzhou LBP Medicine Science & Technology
- 16.75
- -0.34-1.99%
Market Closed Jan 3 15:00 CST
1.57BMarket Cap48.83P/E (TTM)
17.33High16.72Low8.59KlotVolume17.13Open17.09Pre Close14.56MTurnover1.41%Turnover Ratio39.14P/E (Static)93.57MShares23.8352wk High1.23P/B1.02BFloat Cap12.6852wk Low20.51Limit Up60.80MShs Float73.16Historical High13.67Limit Down3.57%Amplitude12.68Historical Low0.15Dividend TTM16.95Avg Price5.22KlotAsk0.90%Div YieldTTM100Lot Size3.19KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Guangzhou LBP Medicine Science & Technology: The HER2 gene testing kit (fluorescence in situ hybridization method) has received approval for medical instruments change registration.
Guangzhou LBP Medicine Science & Technology (688393.SH): The cervical cytology AI-assisted system is currently in the registration application stage for Class III certification.
On December 30, Gelonghui reported that Guangzhou LBP Medicine Science & Technology (688393.SH) disclosed the record of investor relations activities indicating that the company's cervical cytology AI-assisted system is currently in the registration phase for Class III certification. The main issue this product addresses is screening work. There is a relative shortage of pathologists in the country, and cytological diagnosis particularly relies on the interpretation of doctors. The anticipated scenario is that AI will handle most of the screening work, allowing doctors to focus their main attention on suspicious points, thereby improving diagnostic efficiency and accuracy. The product has annotated over 1 million field images and over 2.6 million cells, in 9 medical centers.
Express News | Guangzhou LBP Medicine Science & Technology: The cervical cytology AI-assisted system developed in collaboration with Tencent AI Lab is currently undergoing registration for Class III certification.
Guangzhou LBP Medicine Science & Technology (688393.SH): Core technical staff Su Zhongchun has resigned.
Guangzhou LBP Medicine Science & Technology (688393.SH) announced that the company's core technical staff, Su Zhongchun, recently applied for resignation due to personal reasons...
Express News | Summary of Shareholding adjustments on December 17.
Express News | Guangzhou LBP Medicine Science & Technology: Shareholders intend to reduce their Shareholding to no more than 3.00% of the company's shares.
